HCA Healthcare vs Sanofi

HCA Healthcare (HCA), health care, and Sanofi (SNY), health care, side by side on market value, valuation, margins, balance sheet and price change. Higher and lower are marked; neither is called better.

Sanofi is worth $115B on the stock market and HCA Healthcare $105.1B: Sanofi is valued at 9% more. HCA Healthcare trades at 16.7 times earnings and Sanofi at 23.8. Over the past year HCA Healthcare's share price has moved +7.04% and Sanofi's -4.48%.

Key facts

HCA Healthcare market value
$105.1B
Sanofi market value
$115B
HCA Healthcare P/E
16.7
Sanofi P/E
23.8
HCA Healthcare revenue
$75.6BFY to 2025-12-31
Sanofi revenue
$48.4BFY to 2025-12-31
Superinvestors holding both
2

Market values as of .

HCA Healthcare vs Sanofi: every measure side by side
Measure HCA Healthcare Sanofi
SectorHealth CareHealth Care
Country United States France
Fiscal year ends2025-12-312025-12-31
Size
Market cap$105.1Blower$115Bhigher
Revenue$75.6Bhigher$48.4Blower
Earnings$6.8Blower$8.7Bhigher
Employees230,000higher74,846lower
Total assets$60.7Blower$140.7Bhigher
Valuation
P/E16.7lower23.8higher
P/S1.4lower2.4higher
P/B——
Dividend yield0.60%—
Profitability
Operating margin—14.5%
Balance sheet
Net assets-$6Blower$79.2Bhigher
Total liabilities$63.5Bhigher$61.1Blower
Total debt$46.5Bhigher$20.8Blower
Cash on hand$1Blower$8.5Bhigher
Price change
Today-1.67%lower-1.05%higher
1 year+7.04%higher-4.48%lower

Market value, P/E, P/B, dividend yield and price changes are from live quotes (Yahoo Finance; prices may be delayed 15 minutes or more). Revenue, earnings, operating margin and the balance-sheet figures are from each company's latest annual report filed with the SEC (collected 2026-11-12); a company that reports in another currency is converted to US dollars at the exchange rate of that day. P/S sets today's market value against the latest fiscal year's revenue. “Higher” and “lower” compare the two numbers only; a higher P/E or more debt is not better. Dividend yield and P/B are shown only for companies based in the US. A dash means no figure is on file.

Loading the one-year price chart…

Which superinvestors hold them

From each tracked investor's latest 13F filing. A 13F lists long positions in US-listed shares at a quarter end, filed up to 45 days later.

Percentages are each holding's share of that investor's reported portfolio (under "Both": HCA Healthcare / Sanofi). Who owns HCA · Who owns SNY

Further comparisons

Learn

Questions and answers

Which is bigger, HCA Healthcare or Sanofi?

By market value, Sanofi is the larger: $115B against $105.1B for HCA Healthcare. By revenue in its latest fiscal year, HCA Healthcare is the larger: $75.6B against $48.4B for Sanofi.

Which has the higher P/E ratio?

Sanofi: 23.8, against 16.7 for HCA Healthcare. A higher P/E means the market pays more for each dollar of the last twelve months' earnings; on its own it does not say which is the better value.

Which has more debt?

HCA Healthcare: $46.5B, against $20.8B for Sanofi. Total debt is borrowings at the end of the latest fiscal year, as each company reported it; it is not set against cash here.

Which superinvestors own both HCA Healthcare and Sanofi?

In their latest 13F filings, Charles Brandes (founder) and Richard Pzena hold both.

Cite this page

Funkfolio, “HCA Healthcare vs Sanofi”, data as of 17 November 2026. https://funkfolio.com/compare/hca-vs-sny

Underlying data: Yahoo Finance quotes; SEC annual reports collected 2026-11-12; 13F filings.